Penumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Publicado el 26 de julio de 2017 · Inicio del retiro: 9 de junio de 2017
Resumen
FDA registra el retiro Z-2702-2017 de dispositivos médicos de Clase I, publicado el 26 de julio de 2017 e iniciado el 9 de junio de 2017. Empresa responsable: Penumbra Inc.; Estado: Finalizado; Cantidad reportada: 155 units; Lote: Lots C00644, C00645, C00646, C00717. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Penumbra has identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Penumbra Inc.
- Distribuidor
- Nationwide Distribution to the following states: AZ, CA, CO, FL, IN, MA, MI, MN, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, WV
- Lote
- Lots C00644, C00645, C00646, C00717
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDABrand Name: Penumbra System (RED 62 Reperfusion Catheter) Product Name: Penumbra System (RED 62 Reperfusion7 de octubre de 2026
- FDAStandex International Bakers Pride Microwave Ovens Model E30026 de julio de 2017
- FDAAgfa Healthcare NX 3.0.8950 Imaging Processing Software26 de julio de 2017
- FDAB96331, BREADER, NET WT 50 LBS, Manufactured By: Newly Weds Foods, Inc., Chicago, IL 6063926 de julio de 2017
- FDAPROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number26 de julio de 2017
- FDAB94594, BREADER X1@, NET WT 50 LBS, Manufactured By: Newly Weds Foods, Inc., Chicago, IL 6063926 de julio de 2017
Preguntas sobre este retiro
¿Penumbra 3D Revascularization Device It is indicated for used in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral-M1 and M2 segments) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2702-2017 el 26 de julio de 2017. Peligro reportado: Penumbra has identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter